. 2018 Dec 18;21(3):338. doi: 10.4081/ripppo.2018.338

Table 1.

Changes in symptoms and functioning across timepoints.

	Baseline	Post-treatment	Follow-up	Effect size baseline	Effect size follow-up
Measure	Mean (SD)	Mean (SD)	Mean (SD)	d	d
CORE-OM Total	17.66 (5.44)	12.98 (8.17)	13.72 (8.38)	0.46	0.59
Wellbeing	25.89 (5.33)	15.89 (9.43)^a	18.54 (8.21)^b	0.91	0.93
Problems	21.13 (7.92)	15.89 (8.45)	15.97 (10.1)	0.41	0.61
Functioning	18.03 (6.22)	12.97 (9.46)	13.75 (8.52)	0.52	0.63
Risk	4.52 (4.82)	5.23 (9.51)	5 (8.4)	0.07	0.14
Total without Risk	20.48 (5.98)	14.64 (8.27)	15.59 (8.88)^b	0.56	0.66
DERS Total	107.6 (24.1)	90.66 (23.6)^a	88.1 (13.44)^b	0.74	0.88
NonAccept	16.08 (6.69)	12.5 (4.58)	13.54 (4.45)	0.53	0.5
Goals	17.5 (4.52)	16.5 (4.23)	16.36 (4.17)	0.25	0.41
Impulse	17.08 (5.74)	13.33 (3.79)^a	14.81 (3.6)	0.82	0.27
Aware	17.5 (4.31)	14.5 (4.85)^a	12.81 (4.6)^b	0.85	1.17
Strategies	23.83 (7.1)	20.91 (7.47)	19.27 (3.97)	0.4	0.63
Clarity	15.66 (5.22)	12.91 (4.77)	11.27 (2.79)^b	0.44	0.8
MAS
Self-Reflectivity	4.2 (1.3)	5.06 (1.08)^a	-	1.35	-
Others	3.4 (1.02)	3.9 (0.78)^a	-	0.88	-
Decentration	1.66 (0.89)	1.7 (0.72)^a	-	0.71	-
Mastery	3.33 (1.12)	4.16 (1.2)^a	-	0.97	-
TAS Total	55.78 (12.7)	46.35 (14.7)^a	47.5 (14.96)^b	0.82	1.93
Describing Feelings	16.42 (4.36)	12.78 (5.29)^a	14.25 (4.99)^b	0.72	0.81
Identifying Feelings	19.64 (5.34)	15.57 (5.34)^a	16 (6.57)^b	0.7	1.08
Thinking	19.71 (5.73)	18.28 (5.84)	17.25 (5.61)	0.45	0.52

CORE-OM, Clinical Outcomes in Routine Evaluation Outcome Measure; DERS, Difficulties in Emotion regulation scales; MAS, Metacognition Assessment Scale; TAS, Toronto Alexithymia Scale.

^aSignificant difference of P<.05 between baseline and post-treatment

^bSignificant difference of P<.05 between baseline and follow-up.